{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:01:48Z","timestamp":1787738508196,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Harrington Discovery Institute"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01 AG037637"],"award-info":[{"award-number":["R01 AG037637"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12035-019-01684-9","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T21:02:13Z","timestamp":1561496533000},"page":"8364-8375","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Chronic Dyrk1 Inhibition Delays the Onset of AD-Like Pathology in 3xTg-AD Mice"],"prefix":"10.1007","volume":"56","author":[{"given":"R.","family":"Velazquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Meechoovet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Oddo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hulme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-9353","authenticated-orcid":false,"given":"Travis","family":"Dunckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"issue":"2\u20133","key":"1684_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s12035-010-8137-1","volume":"41","author":"SA Frautschy","year":"2010","unstructured":"Frautschy SA, Cole GM (2010) Why pleiotropic interventions are needed for Alzheimer\u2019s disease. Mol Neurobiol 41(2\u20133):392\u2013409","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1684_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.nurt.2008.10.031","volume":"6","author":"JJ Buccafusco","year":"2009","unstructured":"Buccafusco JJ (2009) Multifunctional receptor-directed drugs for disorders of the central nervous system. Neurotherapeutics. 6(1):4\u201313","journal-title":"Neurotherapeutics."},{"issue":"3","key":"1684_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1021\/jm7009364","volume":"51","author":"A Cavalli","year":"2008","unstructured":"Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C (2008) Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem 51(3):347\u2013372","journal-title":"J Med Chem"},{"issue":"1","key":"1684_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.nurt.2008.10.030","volume":"6","author":"O Weinreb","year":"2009","unstructured":"Weinreb O, Mandel S, Bar-Am O, Yogev-Falach M, Avramovich-Tirosh Y, Amit T, Youdim MBH (2009) Multifunctional neuroprotective derivatives of rasagiline as anti-Alzheimer\u2019s disease drugs. Neurotherapeutics. 6(1):163\u2013174","journal-title":"Neurotherapeutics."},{"issue":"1","key":"1684_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/hmg\/ddl437","volume":"16","author":"R Kimura","year":"2007","unstructured":"Kimura R, Kamino K, Yamamoto M, Nuripa A, Kida T, Kazui H, Hashimoto R, Tanaka T et al (2007) The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease. Hum Mol Genet 16(1):15\u201323","journal-title":"Hum Mol Genet"},{"issue":"48","key":"1684_CR6","doi-asserted-by":"publisher","first-page":"34850","DOI":"10.1074\/jbc.M707358200","volume":"282","author":"SR Ryoo","year":"2007","unstructured":"Ryoo SR, Jeong HK, Radnaabazar C, Yoo JJ, Cho HJ, Lee HW, Kim IS, Cheon YH et al (2007) DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease. J Biol Chem 282(48):34850\u201334857","journal-title":"J Biol Chem"},{"issue":"18","key":"1684_CR7","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1093\/hmg\/10.18.1915","volume":"10","author":"X Altafaj","year":"2001","unstructured":"Altafaj X, Dierssen M, Baamonde C, Marti E, Visa J, Guimera J et al (2001) Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down\u2019s syndrome. Hum Mol Genet 10(18):1915\u20131923","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1684_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.nbd.2005.12.006","volume":"22","author":"KJ Ahn","year":"2006","unstructured":"Ahn KJ, Jeong HK, Choi HS, Ryoo SR, Kim YJ, Goo JS, Choi SY, Han JS et al (2006) DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects. Neurobiol Dis 22(3):463\u2013472","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1684_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.nbd.2005.03.020","volume":"20","author":"I Ferrer","year":"2005","unstructured":"Ferrer I, Barrachina M, Puig B, Martinez de Lagran M, Marti E, Avila J et al (2005) Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models. Neurobiol Dis 20(2):392\u2013400","journal-title":"Neurobiol Dis"},{"issue":"9","key":"1684_CR10","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1096\/fj.07-104539","volume":"22","author":"F Liu","year":"2008","unstructured":"Liu F, Liang Z, Wegiel J, Hwang YW, Iqbal K, Grundke-Iqbal I, Ramakrishna N, Gong CX (2008) Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome. FASEB J 22(9):3224\u20133233","journal-title":"FASEB J"},{"key":"1684_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2164-11-25","volume":"11","author":"DO Azorsa","year":"2010","unstructured":"Azorsa DO, Robeson RH, Frost D, Meec hoovet B, Brautigam GR, Dickey C et al (2010) High-content siRNA screening of the kinome identifies kinases involved in Alzheimer\u2019s disease-related tau hyperphosphorylation. BMC Genomics 11:25","journal-title":"BMC Genomics"},{"key":"1684_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.nbd.2012.11.017","volume":"52","author":"X Altafaj","year":"2013","unstructured":"Altafaj X, Martin ED, Ortiz-Abalia J, Valderrama A, Lao-Peregrin C, Dierssen M et al (2013) Normalization of Dyrk1A expression by AAV2\/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome. Neurobiol Dis 52:117\u2013127","journal-title":"Neurobiol Dis"},{"key":"1684_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ejmech.2018.08.093","volume":"158","author":"A Pathak","year":"2018","unstructured":"Pathak A, Rohilla A, Gupta T, Akhtar MJ, Haider MR, Sharma K, Haider K, Yar MS (2018) DYRK1A kinase inhibition with emphasis on neurodegeneration: a comprehensive evolution story-cum-perspective. Eur J Med Chem 158:559\u2013592","journal-title":"Eur J Med Chem"},{"issue":"5","key":"1684_CR14","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1471-4159.2007.05075.x","volume":"104","author":"SR Ryoo","year":"2008","unstructured":"Ryoo SR, Cho HJ, Lee HW, Jeong HK, Radnaabazar C, Kim YS, Kim MJ, Son MY et al (2008) Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer\u2019s disease. J Neurochem 104(5):1333\u20131344","journal-title":"J Neurochem"},{"issue":"44","key":"1684_CR15","doi-asserted-by":"publisher","first-page":"33250","DOI":"10.1074\/jbc.M606147200","volume":"281","author":"EJ Kim","year":"2006","unstructured":"Kim EJ, Sung JY, Lee HJ, Rhim H, Hasegawa M, Iwatsubo T, Min DS, Kim J et al (2006) Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation. J Biol Chem 281(44):33250\u201333257","journal-title":"J Biol Chem"},{"issue":"4","key":"1684_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00401-008-0419-6","volume":"116","author":"J Wegiel","year":"2008","unstructured":"Wegiel J, Dowjat K, Kaczmarski W, Kuchna I, Nowicki K, Frackowiak J, Mazur Kolecka B, Wegiel J et al (2008) The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome. Acta Neuropathol 116(4):391\u2013407","journal-title":"Acta Neuropathol"},{"issue":"40","key":"1684_CR17","doi-asserted-by":"publisher","first-page":"25893","DOI":"10.1074\/jbc.273.40.25893","volume":"273","author":"W Becker","year":"1998","unstructured":"Becker W, Weber Y, Wetzel K, Eirmbter K, Tejedor FJ, Joost HG (1998) Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. J Biol Chem 273(40):25893\u201325902","journal-title":"J Biol Chem"},{"issue":"2","key":"1684_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/mnfr.201300325","volume":"58","author":"R De la Torre","year":"2014","unstructured":"De la Torre R, De Sola S, Pons M, Duchon A, de Lagran MM, Farre M et al (2014) Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans. Mol Nutr Food Res 58(2):278\u2013288","journal-title":"Mol Nutr Food Res"},{"issue":"5","key":"1684_CR19","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/acel.12648","volume":"16","author":"C Branca","year":"2017","unstructured":"Branca C, Shaw DM, Belfiore R, Gokhale V, Shaw AY, Foley C, Smith B, Hulme C et al (2017) Dyrk1 inhibition improves Alzheimer\u2019s disease-like pathology. Aging Cell 16(5):1146\u20131154","journal-title":"Aging Cell"},{"issue":"1","key":"1684_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/archneur.1995.00540250089017","volume":"52","author":"LM Bierer","year":"1995","unstructured":"Bierer LM, Hof PR, Purohit DP, Carlin L, Schmeidler J, Davis KL, Perl DP (1995) Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer\u2019s disease. Arch Neurol 52(1):81\u201388","journal-title":"Arch Neurol"},{"issue":"2","key":"1684_CR21","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.mcn.2007.07.007","volume":"36","author":"J Park","year":"2007","unstructured":"Park J, Yang EJ, Yoon JH, Chung KC (2007) Dyrk1A overexpression in immortalized hippocampal cells produces the neuropathological features of Down syndrome. Mol Cell Neurosci 36(2):270\u2013279","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"1684_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1742-4658.2010.07955.x","volume":"278","author":"J Wegiel","year":"2011","unstructured":"Wegiel J, Gong CX, Hwang YW (2011) The role of DYRK1A in neurodegenerative diseases. FEBS J 278(2):236\u2013245","journal-title":"FEBS J"},{"issue":"14","key":"1684_CR23","doi-asserted-by":"publisher","first-page":"5819","DOI":"10.1073\/pnas.1017033108","volume":"108","author":"M Jin","year":"2011","unstructured":"Jin M, Shepardson N, Yang T, Chen G, Walsh D, Selkoe DJ (2011) Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce tau hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci U S A 108(14):5819\u20135824","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"1684_CR24","doi-asserted-by":"publisher","first-page":"11938","DOI":"10.1523\/JNEUROSCI.2357-10.2010","volume":"30","author":"H Zempel","year":"2010","unstructured":"Zempel H, Thies E, Mandelkow E, Mandelkow EM (2010) Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous tau into dendrites, tau phosphorylation, and destruction of microtubules and spines. J Neurosci 30(36):11938\u201311950","journal-title":"J Neurosci"},{"key":"1684_CR25","doi-asserted-by":"publisher","first-page":"723","DOI":"10.4155\/fmc-2018-0557","volume":"11","author":"J Qi","year":"2019","unstructured":"Qi J, Zhang G (2019) Proteolysis-targeting chimeras for targeting protein for degradation. Future Med Chem 11:723\u2013741","journal-title":"Future Med Chem"},{"issue":"5","key":"1684_CR26","doi-asserted-by":"publisher","first-page":"e19264","DOI":"10.1371\/journal.pone.0019264","volume":"6","author":"D Frost","year":"2011","unstructured":"Frost D, Meechoovet B, Wang T, Gately S, Giorgetti M, Shcherbakova I, Dunckley T (2011) Beta-carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer\u2019s disease-related sites. PLoS One 6(5):e19264","journal-title":"PLoS One"},{"issue":"8","key":"1684_CR27","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","volume":"24","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer\u2019s disease. Neurobiol Aging 24(8):1063\u20131070","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1684_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1742-4658.2010.07956.x","volume":"278","author":"W Becker","year":"2011","unstructured":"Becker W, Sippl W (2011) Activation, regulation, and inhibition of DYRK1A. FEBS J 278(2):246\u2013256","journal-title":"FEBS J"},{"key":"1684_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep12728","volume":"5","author":"R Sonamoto","year":"2015","unstructured":"Sonamoto R, Kii I, Koike Y, Sumida Y, Kato-Sumida T, Okuno Y, Hosoya T, Hagiwara M (2015) Identification of a DYRK1A inhibitor that induces degradation of the target kinase using co-chaperone CDC37 fused with luciferase nanoKAZ. Sci Rep 5:12728","journal-title":"Sci Rep"},{"key":"1684_CR30","doi-asserted-by":"crossref","unstructured":"Belfiore R, Rodin A, Ferreira E, Velazquez R, Branca C, Caccamo A et al (2019) Temporal and regional progression of Alzheimer\u2019s disease-like pathology in 3xTg-AD mice. Aging Cell 18(1):e12873","DOI":"10.1111\/acel.12873"},{"key":"1684_CR31","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1042\/bj3550609","volume":"355","author":"YL Woods","year":"2001","unstructured":"Woods YL, Cohen P, Becker W, Jakes R, Goedert M, Wang X et al (2001) The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem J 355(Pt 3:609\u2013615","journal-title":"Biochem J"},{"issue":"2","key":"1684_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2217\/fnl.12.6","volume":"7","author":"AY Lai","year":"2012","unstructured":"Lai AY, McLaurin J (2012) Clearance of amyloid-beta peptides by microglia and macrophages: the issue of what, when and where. Future Neurol 7(2):165\u2013176","journal-title":"Future Neurol"},{"issue":"3","key":"1684_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","volume":"43","author":"S Oddo","year":"2004","unstructured":"Oddo S, Billings L, Kesslak JP, Cribbs DH, LaFerla FM (2004) Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron. 43(3):321\u2013332","journal-title":"Neuron."},{"issue":"6","key":"1684_CR34","doi-asserted-by":"publisher","first-page":"e00267","DOI":"10.1042\/BSR20150194","volume":"35","author":"L Beke","year":"2015","unstructured":"Beke L, Kig C, Linders JT, Boens S, Boeckx A, van Heerde E et al (2015) MELK-T1, a small-molecule inhibitor of protein kinase MELK, decreases DNA-damage tolerance in proliferating cancer cells. Biosci Rep 35(6):e00267","journal-title":"Biosci Rep"},{"issue":"4","key":"1684_CR35","doi-asserted-by":"publisher","first-page":"e1700247","DOI":"10.1002\/bies.201700247","volume":"40","author":"S Gu","year":"2018","unstructured":"Gu S, Cui D, Chen X, Xiong X, Zhao Y (2018) PROTACs: an emerging targeting technique for protein degradation in drug discovery. Bioessays. 40(4):e1700247","journal-title":"Bioessays."},{"issue":"3","key":"1684_CR36","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1523\/JNEUROSCI.3314-12.2013","volume":"33","author":"A Caccamo","year":"2013","unstructured":"Caccamo A, Medina DX, Oddo S (2013) Glucocorticoids exacerbate cognitive deficits in TDP-25 transgenic mice via a glutathione-mediated mechanism: implications for aging, stress and TDP-43 proteinopathies. J Neurosci 33(3):906\u2013913","journal-title":"J Neurosci"},{"issue":"12","key":"1684_CR37","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1016\/j.neurobiolaging.2014.06.011","volume":"35","author":"C Branca","year":"2014","unstructured":"Branca C, Wisely EV, Hartman LK, Caccamo A, Oddo S (2014) Administration of a selective beta2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer\u2019s disease. Neurobiol Aging 35(12):2726\u20132735","journal-title":"Neurobiol Aging"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01684-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-01684-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01684-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T23:19:33Z","timestamp":1592954373000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-01684-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1684"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-01684-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]},"assertion":[{"value":"17 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal care and treatments were in accordance with the applicable regulation of the vivarium (The Institutional Animal Care and Use Committee of the Arizona State University).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}}]}}